Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dusan Ruzic

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Chemical Information and Modeling|April 25, 2022
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket DynamicsNemanja Djokovic, Dusan Ruzic, Minna Rahnasto-Rilla, et al.
Pharmaceutics|November 25, 2023
Targeting Histone Deacetylases 6 in Dual-Target Therapy of CancerMilan Beljkas, Aleksandra Ilic, Alen Cebzan, et al.
British Journal of Pharmacology|May 9, 2024
Targeting noncoding RNAs to treat atherosclerosisMiron Sopić, Sandra Vladimirov, Jelena Munjas, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and ModelingSamuel Bouchet, Camille Linot, Dusan Ruzic, et al.
Cancers|December 11, 2022
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia CellsIpek Bulut, Adam Lee, Buse Cevatemre, et al.
Future Medicinal Chemistry|March 25, 2022
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studiesCorentin Bon, Magdalena Barbachowska, Nemanja Djokovic, et al.
Chembiochem : a European Journal of Chemical Biology|January 25, 2019
Modulating Protein-Protein Interactions with Visible-Light-Responsive Peptide Backbone PhotoswitchesLea Albert, Alberto Peñalver, Nemanja Djokovic, et al.
Open Biology|February 18, 2025
The histone deacetylase inhibitor Scriptaid targets G-quadruplexesVictoria Sanchez-Martin, Dusan Ruzic, Maria J Tello-Lopez, et al.
Molecular Informatics|March 31, 2021
An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main ProteaseNemanja Djokovic, Dusan Ruzic, Teodora Djikic, et al.
Pharmaceutics|December 23, 2022
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological EvaluationDusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Chemical Information and Modeling|April 25, 2022
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket DynamicsNemanja Djokovic, Dusan Ruzic, Minna Rahnasto-Rilla, et al.
Pharmaceutics|November 25, 2023
Targeting Histone Deacetylases 6 in Dual-Target Therapy of CancerMilan Beljkas, Aleksandra Ilic, Alen Cebzan, et al.
British Journal of Pharmacology|May 9, 2024
Targeting noncoding RNAs to treat atherosclerosisMiron Sopić, Sandra Vladimirov, Jelena Munjas, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and ModelingSamuel Bouchet, Camille Linot, Dusan Ruzic, et al.
Cancers|December 11, 2022
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia CellsIpek Bulut, Adam Lee, Buse Cevatemre, et al.
Future Medicinal Chemistry|March 25, 2022
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studiesCorentin Bon, Magdalena Barbachowska, Nemanja Djokovic, et al.
Chembiochem : a European Journal of Chemical Biology|January 25, 2019
Modulating Protein-Protein Interactions with Visible-Light-Responsive Peptide Backbone PhotoswitchesLea Albert, Alberto Peñalver, Nemanja Djokovic, et al.
Open Biology|February 18, 2025
The histone deacetylase inhibitor Scriptaid targets G-quadruplexesVictoria Sanchez-Martin, Dusan Ruzic, Maria J Tello-Lopez, et al.
Molecular Informatics|March 31, 2021
An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main ProteaseNemanja Djokovic, Dusan Ruzic, Teodora Djikic, et al.
Pharmaceutics|December 23, 2022
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological EvaluationDusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, et al.
Pageof 3